Literature DB >> 24432118

The efficacy of neuroprosthesis in young hemiplegic patients, measured by three different gait indices: early results.

Barry Danino1, Sam Khamis1, Yoram Hemo1, Reuven Batt1, Erel Snir1, Shlomo Wientroub1, Shlomo Hayek1.   

Abstract

PURPOSE: To evaluate functional electrical stimulation (FES) neuroprothesis as a method to improve gait in hemiplegic patients, using three different gait scoring methods as measures.
METHODS: Five hemiplegic patients (four with cerebral palsy at GMFCS I, one with diffuse pontine glioma) with a mean age of 16.5 years were given a FES neuroprosthesis (NESS(®) L300™) that was applied and calibrated individually. After an adaptation period during which the participants increased their daily use of the neuroprosthesis, gait was assessed with the stimulation off and with the FES on. Kinematic, kinetic, and temporal spatial data were determined using motion analysis and summarized by three scoring methods: Gait Profile Score (GPS), Gait Deviation Index (GDI), and Gillette Gait Index (GGI). Indices were calculated using the Gaitabase program available online. Patients were followed for a minimum of 1 year.
RESULTS: When comparing gait with and without stimulation, all scoring methods showed improvement. GPS and GDI of the affected leg were significantly improved: 12.23-10.23° (p = 0.017) and 72.36-78.08 (p = 0.002), respectively. By applying the movement analysis profile, the decomposed GPS score, we found that only the ankle dorsiflexion and the foot progression angle were significantly changed. GGI of the affected leg showed improvement, but without statistical significance: 168.88-131.64 (p = 0.221). Total GPS of legs and the GPS, GDI, and GGI of the nonaffected leg showed improvement without statistical significance. At the 1-year follow-up, all patients expressed high satisfaction and continued to use the device.
CONCLUSIONS: Dorsiflexion functional electrical stimulation improves gait in hemiplegic patients, as reflected by GPS, GDI, and GGI.

Entities:  

Keywords:  Cerebral palsy; Drop foot; Functional electrical stimulation; Gait analysis; Gait indices; Neuroprosthesis

Year:  2013        PMID: 24432118      PMCID: PMC3886350          DOI: 10.1007/s11832-013-0540-5

Source DB:  PubMed          Journal:  J Child Orthop        ISSN: 1863-2521            Impact factor:   1.548


  13 in total

1.  An index for quantifying deviations from normal gait.

Authors:  L M Schutte; U Narayanan; J L Stout; P Selber; J R Gage; M H Schwartz
Journal:  Gait Posture       Date:  2000-02       Impact factor: 2.840

2.  Effects of a new radio frequency-controlled neuroprosthesis on gait symmetry and rhythmicity in patients with chronic hemiparesis.

Authors:  Jeffrey M Hausdorff; Haim Ring
Journal:  Am J Phys Med Rehabil       Date:  2008-01       Impact factor: 2.159

3.  The gait profile score and movement analysis profile.

Authors:  Richard Baker; Jennifer L McGinley; Michael H Schwartz; Sarah Beynon; Adam Rozumalski; H Kerr Graham; Oren Tirosh
Journal:  Gait Posture       Date:  2009-07-24       Impact factor: 2.840

4.  The Gait Deviation Index: a new comprehensive index of gait pathology.

Authors:  Michael H Schwartz; Adam Rozumalski
Journal:  Gait Posture       Date:  2008-06-18       Impact factor: 2.840

5.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

6.  Immediate effect of percutaneous intramuscular stimulation during gait in children with cerebral palsy: a feasibility study.

Authors:  Margo N Orlin; Samuel R Pierce; Carrie Laughton Stackhouse; Brian T Smith; Therese Johnston; Patricia A Shewokis; James J McCarthy
Journal:  Dev Med Child Neurol       Date:  2005-10       Impact factor: 5.449

7.  Effects of a foot drop neuroprosthesis on functional abilities, social participation, and gait velocity.

Authors:  Yocheved Laufer; Jeffrey M Hausdorff; Haim Ring
Journal:  Am J Phys Med Rehabil       Date:  2009-01       Impact factor: 2.159

Review 8.  Rehabilitation of spasticity and related problems in childhood cerebral palsy.

Authors:  P J Flett
Journal:  J Paediatr Child Health       Date:  2003 Jan-Feb       Impact factor: 1.954

9.  Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking.

Authors:  Haim Ring; Iuly Treger; Leor Gruendlinger; Jeffrey M Hausdorff
Journal:  J Stroke Cerebrovasc Dis       Date:  2009-01       Impact factor: 2.136

10.  Gait in individuals with chronic hemiparesis: one-year follow-up of the effects of a neuroprosthesis that ameliorates foot drop.

Authors:  Yocheved Laufer; Haim Ring; Elliot Sprecher; Jeffrey M Hausdorff
Journal:  J Neurol Phys Ther       Date:  2009-06       Impact factor: 3.649

View more
  4 in total

Review 1.  Relationship between ankle function and walking ability for children and young adults with cerebral palsy: A systematic review of deficits and targeted interventions.

Authors:  Benjamin C Conner; Nushka M Remec; Cassidy M Michaels; Chase W Wallace; Emily Andrisevic; Zachary F Lerner
Journal:  Gait Posture       Date:  2021-10-25       Impact factor: 2.840

2.  A functional electrical stimulation system improves knee control in crouch gait.

Authors:  Sam Khamis; Raz Martikaro; Shlomo Wientroub; Yoram Hemo; Shlomo Hayek
Journal:  J Child Orthop       Date:  2015-03-19       Impact factor: 1.548

Review 3.  A Scoping Review of Neuromuscular Electrical Stimulation to Improve Gait in Cerebral Palsy: The Arc of Progress and Future Strategies.

Authors:  Jake A Mooney; Jessica Rose
Journal:  Front Neurol       Date:  2019-08-21       Impact factor: 4.003

4.  Evaluation of Individualized Functional Electrical Stimulation-Induced Acute Changes during Walking: A Case Series in Children with Cerebral Palsy.

Authors:  Nicole Zahradka; Ahad Behboodi; Ashwini Sansare; Samuel C K Lee
Journal:  Sensors (Basel)       Date:  2021-06-29       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.